搜索临床试验以:转铁蛋白-CRM107
总计132个结果
-
Novartis Vaccines完全的
-
National Institute of Allergy and Infectious Diseases...终止
-
The Immunobiological Technology Institute (Bio-Manguinhos)...未知
-
National Institute of Allergy and Infectious Diseases...完全的
-
RevimmuneC.R.O. ReSolution Latin America S.A.终止
-
RevimmuneM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research Institute... 和其他合作者终止
-
RevimmuneWashington University School of Medicine终止
-
RevimmuneWashington University School of Medicine; Amarex Clinical Research终止
-
RevimmuneAmarex Clinical Research终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Revimmune撤销
-
RevimmuneUniversity Hospital, Limoges; Amarex Clinical Research终止
-
CanSino Biologics Inc.Henan Center for Disease Control and Prevention完全的
-
RevimmuneWashington University School of Medicine; Vanderbilt University School of Medicine完全的
-
CanSino Biologics Inc.Henan Center for Disease Control and Prevention完全的
-
Second Affiliated Hospital, School of Medicine,...未知
-
Pfizer完全的
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Cancer Immunotherapy Trials Network完全的
-
RevimmuneWashington University School of Medicine; University Hospital, Limoges; George Clinical Pty Ltd终止
-
The Jackson LaboratoryUniversity of Alabama at Birmingham; UConn Health完全的
-
Cytheris SA未知
-
Pfizer主动,不招人斑秃美国, 西班牙, 中国, 大韩民国, 台湾, 澳大利亚, 加拿大, 德国, 捷克语, 波兰, 日本, 英国, 墨西哥, 阿根廷, 智利, 哥伦比亚, 俄罗斯联邦
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)招聘中弥漫性大 B 细胞淋巴瘤 | 复发性套细胞淋巴瘤 | 复发性边缘区淋巴瘤 | 难治性 B 细胞非霍奇金淋巴瘤 | 复发性 B 细胞非霍奇金淋巴瘤 | 难治性套细胞淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 复发性华氏巨球蛋白血症 | 复发性惰性成人非霍奇金淋巴瘤 | 转化的复发性非霍奇金淋巴瘤 | 复发性结外边缘区淋巴瘤 | 难治性结外边缘区淋巴瘤 | III 期非霍奇金淋巴瘤 | IV 期非霍奇金淋巴瘤美国